Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
How did CARL's recent EPS compare to expectations?
The most recent EPS for Carlsmed Inc is $, expectations of $-0.39.
How did Carlsmed Inc CARL's revenue perform in the last quarter?
Carlsmed Inc revenue for the last quarter is $
What is the revenue estimate for Carlsmed Inc?
According to 7 of Wall street analyst, the revenue estimate of Carlsmed Inc range from $18.42M to $16.58M
What's the earning quality score for Carlsmed Inc?
Carlsmed Inc has a earning quality score of B+/57.075027. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Carlsmed Inc report earnings?
Carlsmed Inc next earnings report is expected in 2026-08-03
What are Carlsmed Inc's expected earnings?
Carlsmed Inc expected earnings is $15.28M, according to wall-street analysts.